These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 15252181)

  • 1. Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients.
    Benyahia M; Shahapuni I; Ghazali A; Massy Z; Fournier A
    Nephrol Dial Transplant; 2004 Aug; 19(8):2153; author reply 2153-4. PubMed ID: 15252181
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone mineral density in the distal radius and increased risk of fractures in haemodialysis.
    Ghosh AK
    Nephrol Dial Transplant; 2004 Apr; 19(4):1012; author reply 1012-3. PubMed ID: 15031371
    [No Abstract]   [Full Text] [Related]  

  • 3. Leptin and biochemical markers of bone turnover in dialysis patients.
    Zoccali C; Panuccio V; Tripepi G; Cutrupi S; Pizzini P; Mallamaci F
    J Nephrol; 2004; 17(2):253-60. PubMed ID: 15293526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of bone mineral density and bone metabolism in children with multiple bone fractures.
    Michałus I; Chlebna-Sokół D; Rusińska A; Jakubowska-Pietkiewicz E; Kulińska-Szukalska K
    Ortop Traumatol Rehabil; 2008; 10(6):602-12. PubMed ID: 19153549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fracture risk after parathyroidectomy among chronic hemodialysis patients.
    Rudser KD; de Boer IH; Dooley A; Young B; Kestenbaum B
    J Am Soc Nephrol; 2007 Aug; 18(8):2401-7. PubMed ID: 17634437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women.
    Garnero P; Delmas PD
    J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):50-63. PubMed ID: 15615078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Parathyroid and bone. Skeletal derangement in patients with primary hyperparathyroidism].
    Takeuchi Y
    Clin Calcium; 2007 Dec; 17(12):1815-21. PubMed ID: 18057655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of adynamic bone disease in uremia.
    Fournier A; Said S; Ghazali A; Sechet A; Ezaitouni F; Marie A; Westeel PF; Morinière P; Boudailliez B
    Adv Nephrol Necker Hosp; 1997; 27():131-66. PubMed ID: 9408446
    [No Abstract]   [Full Text] [Related]  

  • 9. [New assay for parathyroid hormone].
    Inaba M
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():306-11. PubMed ID: 16279652
    [No Abstract]   [Full Text] [Related]  

  • 10. Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis.
    Jamal SA; Hayden JA; Beyene J
    Am J Kidney Dis; 2007 May; 49(5):674-81. PubMed ID: 17472850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of intact parathyroid hormone level is a risk factor for low bone mineral density in pretransplant patients with liver diseases.
    Bai XL; Liang TB; Wu LH; Li DL; Geng L; Wang WL; Shen Y; Zhang M; Zheng SS
    Transplant Proc; 2007 Dec; 39(10):3182-5. PubMed ID: 18089348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis.
    Danese MD; Kim J; Doan QV; Dylan M; Griffiths R; Chertow GM
    Am J Kidney Dis; 2006 Jan; 47(1):149-56. PubMed ID: 16377396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation.
    Dolgos S; Hartmann A; Bønsnes S; Ueland T; Isaksen GA; Godang K; Pfeffer P; Bollerslev J
    Clin Transplant; 2008; 22(4):462-8. PubMed ID: 18318737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
    Karner I; Hrgović Z; Sijanović S; Buković D; Klobucar A; Usadel KH; Fassbender WJ
    Eur J Med Res; 2005 Nov; 10(11):480-8. PubMed ID: 16354602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of bone health and osteoporosis risk.
    Eastell R; Hannon RA
    Proc Nutr Soc; 2008 May; 67(2):157-62. PubMed ID: 18412989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum leptin level and the risk of nontraumatic fracture.
    Schett G; Kiechl S; Bonora E; Redlich K; Woloszczuk W; Oberhollenzer F; Jocher J; Dorizzi R; Muggeo M; Smolen J; Willeit J
    Am J Med; 2004 Dec; 117(12):952-6. PubMed ID: 15629735
    [No Abstract]   [Full Text] [Related]  

  • 17. Low bone mineral density and fracture burden in postmenopausal women.
    Cranney A; Jamal SA; Tsang JF; Josse RG; Leslie WD
    CMAJ; 2007 Sep; 177(6):575-80. PubMed ID: 17846439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between leptin and bone mineral density in renal transplant recipients.
    Agras PI; Baskin E; Saatci U; Colak T; Cengiz N; Kinik ST; Isiklar I; Haberal A; Mert I; Haberal M
    Transplant Proc; 2005 Sep; 37(7):3106-8. PubMed ID: 16213321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
    Uretmen S; Gol M; Cimrin D; Irmak E
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex steroids and bone turnover markers in men with symptomatic vertebral fractures.
    Tuck SP; Scane AC; Fraser WD; Diver MJ; Eastell R; Francis RM
    Bone; 2008 Dec; 43(6):999-1005. PubMed ID: 18817902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.